Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome?
Although the benefits of next-generation sequencing (NGS) for the diagnosis of heterogeneous diseases such as intellectual disability (ID) are undisputed, there is little consensus on the relative merits of targeted enrichment, whole-exome sequencing (WES) or whole-genome sequencing (WGS). To answer...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Artigo |
Sprache: | Englisch |
Veröffentlicht: |
2015
|
Online-Zugang: | https://doi.org/10.1002/humu.22783 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|